Among top genes/pathways downregulated upon TSA treatment, FGFR1, SMO (receptor for the Hedgehog pathway) and Notch1 have been previously been implicated in promoting tumorigenesis of ERMS [3, 7, 19–21]. This evidence concerns the gene SMO and embryonal rhabdomyosarcoma.